EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Promoting astrocytic activity genetically and pharmacologically increases locomotor function after spinal cord injury in mice

Arthur Sefiani, Theresa C Sutherland, Darijana Horvat, Cédric G Geoffroy

Biochemical and Biophysical Research Communications · 2026-11 · 841 · 154807

DOI: 10.1016/j.bbrc.2026.154807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-11. Verfasst von Arthur Sefiani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX, United States; NeuroCreis, Inc., Col…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Astrocytes, Locomotion. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Morton Cure Paralysis Fund, National Institute of Neurological Disorders and Stroke, Texas A&M University Health Sciences Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After traumatic spinal cord injury (SCI), astrocytes become activated and through a cascade of events, lead to the formation of a glial scar. The glial scar has long been thought to be detrimental to recovery, via reduction of plasticity and axon growth, and the release of pro-inflammatory cytokines into the local environment. However, it has a beneficial role as well; astrocytes in the glial scar can provide a scaffold for growing axons, and the astroglial border functions to sequester the inflammatory lesion, prevent its detrimental expansion, and reduce secondary tissue loss. Therefore, promoting the glial border in the acute phases may promote functional recovery after SCI. We show that promoting astrogliosis by SOCS3 deletion, a negative regulator of STAT3, in primary astrocytes improves 'wound' closure in a wound healing assay. This was consistent in vivo with SOCS3 deletion in spinal astrocytes at the lesion site almost significantly reducing the size of the lesion and significantly improving functional locomotor recovery on a rotarod. Finding drugs that can promote acute wound healing (astroglial border formation) is of therapeutic interest. To this end, we developed an astrocytic wound healing assay that incorporates primary adult mouse astrocytes and a novel scratch tool that reduces variance and allows high-throughput capabilities. We identified Dyclonine, an FDA-approved sodium channel modulator, as a therapeutic candidate for SCI as it reduced the size of the wound in vitro and promoted locomotor function on a rotarod after SCI. We demonstrate here the utility of our astrocytic wound healing assay for the identification of new therapeutic strategies for SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesAstrocytesLocomotionAnimalsSuppressor of Cytokine Signaling 3 ProteinMiceRecovery of FunctionMice, Inbred C57BLMice, KnockoutWound HealingFemaleCells, Cultured

Stichwörter der Autor:innen

AstrocytesAstrogliosisDyclonineSOCS3 knock-outScar formationSpinal cord injuryWound healing assay

Substanzen

Suppressor of Cytokine Signaling 3 ProteinSocs3 protein, mouse

Autor:innen und Institutionen

  • Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX, United States; NeuroCreis, Inc., College Station, TX, United States.
  • Department of Neuroscience and Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, TX, United States.
  • Wolfson Sensory, Pain and Regeneration Centre (SPaRC), King's College London, London, SE1 1UL, United Kingdom; NeuroCreis, Inc., College Station, TX, United States. Electronic address: cedric.geoffroy@kcl.ac.uk.

Förderung

  • Morton Cure Paralysis Fund
  • National Institute of Neurological Disorders and Stroke
  • Texas A&M University Health Sciences Center

Zitieren

APA

Sefiani, A., Sutherland, T. C., Horvat, D., & Geoffroy, C. G. (2026). Promoting astrocytic activity genetically and pharmacologically increases locomotor function after spinal cord injury in mice. Biochemical and Biophysical Research Communications, 841, 154807. https://doi.org/10.1016/j.bbrc.2026.154807

Vancouver

Sefiani A, Sutherland TC, Horvat D, Geoffroy CG. Promoting astrocytic activity genetically and pharmacologically increases locomotor function after spinal cord injury in mice. Biochemical and Biophysical Research Communications. 2026;841:154807. doi:10.1016/j.bbrc.2026.154807

BibTeX
@article{Sefiani2026,
  author = {Sefiani, Arthur and Sutherland, Theresa C and Horvat, Darijana and Geoffroy, Cédric G},
  title = {Promoting astrocytic activity genetically and pharmacologically increases locomotor function after spinal cord injury in mice},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {841},
  pages = {154807},
  doi = {10.1016/j.bbrc.2026.154807}
}
Kostenlos starten →